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Abstract 
Objective 
This study aimed to examine the relationship between pre-screening expectations and 
psychological responses to low-dose computerised tomography (LDCT) screening among high-risk 
individuals in the United Kingdom Lung Cancer Screening (UKLS) pilot trial. 
 
Methods 
Prior to screening, high-risk individuals randomised into the intervention arm of the UKLS were 
asked about their expected screening test result.  Their actual CT scan result was compared with 
their baseline screening expectation to determine the level of congruence. Levels of concern about 
and perceived accuracy of the result were assessed in a questionnaire two weeks following receipt 
of their test result.  
 
Results 
The sample included 1589 participants. Regardless of their expected results, patients who required 
follow-up investigations after their initial CT scan were the most concerned about their result 
(p<0.001). Participants who expected to require follow-up, but did not need it, perceived the test to 
be least accurate (p=0.006).  
 
Conclusions 
Lung cancer screening participants who require follow-up or who have unexpected negative results 
can be identified for supportive interventions. 
 
Practical Implications  
These findings can be used to ensure that any future CT lung cancer screening programme is 
tailored to identify and support those high-risk individuals who may benefit from additional help. 
 
Word count 196  
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1. Introduction 
Lung cancer is the most commonly diagnosed cancer in the world [1] and the third most common in 
the UK [2]. It is the most common cause of cancer death in the UK [2] and is a significant economic 
burden. The average 10-year survival is 5% [3], significantly lower than other cancers, and partly 
attributable to late diagnosis [4]. Lung cancer screening may provide a way to improve lung cancer 
outcomes.  
 
Screening has been shown to reduce mortality and morbidity for other cancers [5,6] and although a 
routine lung screening programme is not yet available, there is evidence that a single low-dose 
computerised tomography (LDCT) scan can detect tumours at early stages [7]. It is more sensitive 
than chest x-ray and enables detection of small, asymptomatic lung tumours [8,9]. A number of 
screening trials for early detection of lung cancer have been or are being conducted [10]. The UKLS 
pilot trial used LDCT screening in a high-risk sample and showed that it is possible to detect cancer 
at an early stage and deliver potentially curative treatment to a large proportion of identified cases 
[11]. The US-based National Lung Cancer Screening Trial (NLST) showed a 20% reduction in lung 
cancer-related mortality in those at high risk when comparing LDCT screening with chest 
radiography [12]. The Dutch-Belgian lung cancer screening trial (NELSON) started in 2003 and the 
final results are yet to be published [13].  
 
Studies of cancer screening in both general and high-risk populations have highlighted adverse 
psychological effects, in particular for abnormal, false positive or inconclusive results [14,15]. Some 
short-term psychological effects may be expected because major diagnoses can be made, but the 
process of screening itself may have negative psychological effects [16]. Identifying patients at a 
greater risk of adverse psychological effects following LDCT for lung cancer screening is important 
so that screening communication strategies can be developed and implemented to prepare and 
support individuals. Within the UKLS pilot trial, levels of distress, anxiety and depression were within 
the normal range at both short- and long-term follow-up [17]. However, those who were called back 
for a follow-up scan showed higher levels of lung cancer distress than those who received a normal 
result, and those who were positive for an MDT referral (multidisciplinary team meeting indicating a 
major lung abnormality) reported higher distress than each of the other result groups [17]. Levels of 
distress in those requiring an MDT referral were approaching clinical thresholds in the short-term 
[17]. These individuals should be identified for additional psychosocial support [18], however there 
may be further factors that could identify who may benefit from more support. Indeed, a number of 
sociodemographic factors (being female, younger, a smoker, from a lower socioeconomic group, 
having experience of lung cancer, recruited from the Liverpool area, or not being 
married/cohabiting) have been shown to be associated with higher lung cancer distress in the UKLS 
sample [17]. Expectation of what the screening result will be is an additional factor that has not 
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yet been explored within this sample that may identify those who could benefit from support 
interventions.  
  
The Cue Adaptive Reasoning Account (CARA) suggests that individuals’ responses to screening 
tests depend partly on the congruence between anticipated and actual results [19]. The model 
proposes that those who receive unexpected or abnormal results will perceive the test result to be 
less accurate and more threatening than those who receive expected normal results [19]. Either 
unexpected or unfavourable information are thought to trigger more elaborate stimulus analysis than 
expected information, and the CARA model assumes that either negative or unexpected feedback 
that conflicts with pre-existing risk perceptions will serve as a cue to draw attentional resources for 
more elaborate stimulus processing [19]. It is not known whether, in the context of the UKLS pilot 
trial, congruence between expected and actual results affects perceived threat (indexed by concern) 
about or perceived accuracy of the result.  
 
The present study aimed to examine the role of screening expectations in modifying psychological 
responses to screening results among high-risk individuals receiving LDCT lung cancer screening. 
Two main hypotheses were tested. Firstly, based on the CARA model, participants with expected 
negative (normal) results would perceive the result to be less concerning and more accurate than 
participants with other results. Secondly, based upon a potential additive effect, those with an 
unexpected abnormal scan result would perceive the result to be more concerning and less 
accurate than participants with other results.  
 
2. Methods 
2.1. Procedures 
UKLS is a multicentre randomised controlled pilot trial to compare LDCT screening versus usual 
care, for the early detection of lung cancer, in high-risk individuals [11,20-22].  
 
A random sample of 247,354 50-75 year olds from six primary care trusts (PCTs; three from the 
Liverpool area and three from the Cambridge area) was invited to participate in the trial. Having 
completed a risk screening questionnaire [23] individuals identified as at high-risk of lung cancer 
were invited to participate. Consenting, eligible participants who attended the study recruitment 
centre were randomised into one of the trial arms: intervention (LDCT) or usual care.  
 
At the recruitment centre, participants completed a baseline questionnaire (T0) including a number 
of psychosocial measures. Participants were sent a follow-up psychosocial questionnaire (T1) 
approximately two weeks after receiving the baseline LDCT scan result letter.  
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2.2. Participants  
High-risk participants were defined as at >5% estimated risk over five years of developing lung 
cancer according to the Liverpool Lung Project Risk Prediction Model [11]. Only those in the 
intervention arm were included in the present study.  
 
2.3. Measures  
2.3.1. Sociodemographic variables 
Age and gender were provided by the PCTs. Age was provided around the time of risk calculation. 
Three age categories were used for some analyses: ≤65 years, 66 to 70 years and ≥71 years, (as 
in the main psycho-social analysis [17]).  
Deprivation was determined using the Index of Multiple Deprivation (IMD), established using 
participants’ postcodes. IMD ranks were categorised using standard quintiles [23]. Quintile one 
reflects the most deprived and quintile five the most affluent. The quintiles were further categorised 
into three groups for some analyses (due to small numbers): greatest deprivation (quintile one), 
intermediate level deprivation (quintiles two, three and four) and lowest deprivation (quintile five). 
Marital group, ethnic background and highest level of education were assessed by participant report 
in the T0 questionnaire. Marital group was categorised into married/cohabiting and not married/not 
cohabiting (single, widowed, divorced/separated). Highest level of education was categorised into 
two groups: up to GCSE/O level or equivalent and beyond GCSE/O level or equivalent.  
Smoking status data were collected at the first stage of the trial [23]. Participants were identified as 
current smokers, ex-smokers or never smokers. Due to small numbers, never smokers were 
excluded from the examination of the association between smoking and both concern about and 
perceived accuracy of the result.   
 
To measure experience of lung cancer, participants were asked in the T0 questionnaire whether 
they, or any of their friends or family members that are close to them, had ever been 
diagnosed with lung cancer. Responses were categorised into two groups: yes (included responses 
“yes, self”, “yes, someone close”, “yes, self and someone close”, “yes, prefer not to say who”) and 
no (response “no”).  
 
2.3.2. Screening result expectation  
Screening expectations were determined in the T0 questionnaire. Participants were asked what 
scan result they expected to receive. Two responses were available “normal/clear scan result”, 
renamed “negative”, and “unclear or abnormal scan result”.  
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2.3.3. LDCT scan result 
Possible scan results were categorised into two groups. Participants who did not require follow-up 
were categorised as “negative”, and participants who did require follow-up were categorised as 
“follow-up”. This follow-up group included those who were positive for a repeat scan (at 3 or 12 
months) or positive for an MDT referral due to a major lung abnormality. (For more details about 
classification of test results, see Field et al. [11,22] and Brain et al. [17]). Those with a “negative 
with incidental finding” result were excluded from the sample because of the wide range of 
incidental findings, hence difficult to categorise further [17].  
 
2.3.4 Expectation-result congruence  
The congruence between screening expectation and actual scan result was examined. Four groups 
were formed: 1) expected negative (expected a negative result and received a negative result), 2) 
unexpected follow-up (expected a negative result but were positive for a repeat scan or MDT 
referral), 3) unexpected negative (expected an unclear/abnormal result but received a negative 
result), 4) expected follow-up (expected an unclear/abnormal result and were positive for a repeat 
scan or MDT referral). 
 
2.3.5. Perceived concern about the LDCT scan result  
Perceived concern about the scan result was measured at T1 by asking participants “how concerned 
were you by your CT scan result?”. This measure was used to represent perceived threat. 
Response options were “not at all concerned”, “not very concerned”, “fairly concerned” and “very 
concerned”.  
 
2.3.6. Perceived accuracy of the LDCT scan result 
Perceived accuracy of the scan result was measured at T1 using the question “how likely do you 
think it was that your CT scan result was false or inaccurate?”. Responses were categorised into 
two (due to small numbers): unlikely that CT scan result was inaccurate (“very unlikely” and 
“unlikely”) and likely that CT scan result was inaccurate (“likely” or “very likely”).  
 
2.4. Analyses 
Statistical analyses were conducted using SPSS v.20. Baseline characteristics between those in the 
present sample and non-completers at T1 were compared using chi-square and t-tests to examine 
drop-out bias. Chi-square tests were used to examine the relationship between congruence and 
both concern about the result and perceived accuracy of the result. Post-hoc pairwise chi-square 
tests were conducted to explore the association between 1) those with expected negative results vs. 
all other expectation-result congruence groups (together; testing hypothesis 1), 2) those with 
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unexpected follow-up results vs. each of the other expectation-result congruence groups 
(individually; testing hypothesis 2). Chi-square tests, ANOVAs (one-way analysis of variance) and t-
tests were used to examine the association between the majority of sociodemographic variables 
and both concern and accuracy of the result. Following a significant ANOVA result (p<0.01), post-
hoc comparisons were carried out using a Tukey test. Ethnic group and highest level of education 
were not included in these analyses due to low variation and substantial missing data respectively. 
A Mantel-Haenszel test was conducted (for the two main chi-square analyses only) as a sensitivity 
analysis to examine potential confounders for the association between congruence and both 
concern and perceived accuracy. Potential confounders were identified if they were statistically 
significantly associated with concern or perceived accuracy. To account for multiple testing, a 
conservative p-value of 0.01 was used. [24] 
 
3. Results  
3.1. Sample 
Figure 1 shows study participation and response rate. Of a total of 4055 individuals randomised, 
2028 were assigned to the intervention arm (LDCT scan) of which 1994 were scanned and included 
in the UKLS CT scan arm [22]. While 1994 participants in the intervention arm were scanned, 1653 
completed questionnaires at both T0 and T1 and were included in the main psycho-social analysis 
[17], and after making further exclusions (details in Figure 1), data from 1589 participants were in 
the final sample. Those in the final sample were significantly more likely to be 
married/cohabiting (p=.004) and have a higher level of education (p=.001) than those who did 
not complete T1 (n=301). Sample characteristics are shown in Table 1. Most participants were 
male and white. The average age was 67.7 years (standard deviation=3.9 years). Three 
quarters of the sample were married or cohabiting. All deprivation groups were reasonably 
represented, with just over a quarter in each of the most and least deprived groups and 
smaller proportions in the other deprivation groups (quintile 2; quintile 3; quintile 4). Over 
half had no experience of lung cancer. The majority were ex-smokers, over a third were 
current smokers and a very small proportion had never smoked.  
 
3.2. Expectation-result congruence and associations with concern about and perceived 
accuracy of the LDCT result 
Most participants (1309; 82.4%) expected a negative result, whereas 280 (17.6%) expected an 
unclear/abnormal result. In reality, 757 (47.6%) participants had a negative result, and 832 (52.4%) 
required follow-up (Table 2).  
 
A significant association was found between expectation-result congruence and concern about the 
result (p<0.001; Table 3). A post-hoc pairwise chi-square test showed a significant association 
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between expectation-result congruence and concern when grouping those who did not have an 
expected negative result together (p<0.001), suggesting that those who received an expected 
negative result were significantly less concerned (56.8% not at all concerned). Three further 
pairwise chi-square tests examined the associations between concern and expectation-result 
congruence for the unexpected follow-up group and each of the other expectation-result 
congruence groups in turn. Significant associations were found between expectation-result and 
concern for the unexpected follow-up group with the two negative result groups (p<0.001); those 
receiving an unexpected follow-up showed more concern (54.3% fairly or very concerned) than 
those with negative results (22.1% and 36.3% fairly or very concerned). However, no significant 
association was found for the two groups requiring follow-up (p=0.1).  
 
A significant association between expectation-result congruence and perceived accuracy of the 
result was found (p=0.006; Table 4). A post-hoc pairwise chi-square test showed that those with an 
expected negative result reported greater perceived accuracy (94.7%) than those who did not have 
an expected negative result (90.5%; p=0.005). There was no significant association between 
expectation-result congruence and perceived accuracy in pairwise comparisons with those receiving 
unexpected follow-up results. However, there was a trend suggesting that those who received 
expected negative results reported greater accuracy than those who received an unexpected follow-
up result (p=0.02). Those receiving an unexpected negative result had the greatest proportion 
(14.3%) that perceived the result to be inaccurate, which was principally contributing to the overall 
association between expectation-result congruence and perceived accuracy. 
 
3.3. Sociodemographic factors  
Age, deprivation and experience of lung cancer were significantly associated with concern about the 
result (Table 5). Those who were very concerned about the result were younger than those who 
were not at all concerned (mean difference -1.17 years, p=0.01). Those in the most deprived group 
were more concerned than the most affluent (p=0.01). Individuals with an experience of lung cancer 
were also more concerned about the result (p=0.01). The Mantel-Haenszel test was conducted for 
age, deprivation and experience of lung cancer. A similar pattern of results was shown within each 
of the levels of these variables for the overall chi-square test including the four expectation-
congruence groups, thus suggesting that they are not significant confounders for the association 
between expectation-result congruence and concern about the result. Smoking status, gender and 
marital group were not significantly associated with concern about the result (Table 5). None of the 
sociodemographic factors were significantly associated with perceived accuracy of the result (Table 
6). 
 
4. Discussion and Conclusion 
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4.1. Discussion 
In the UKLS pilot trial, individuals receiving an expected negative result perceived the test to be less 
concerning and more accurate than those receiving results that were unexpected or requiring 
follow-up, thus supporting the CARA model. A combined effect of both unexpected and abnormal 
results being more concerning and perceived as less accurate was not supported. There was 
however, a non-significant trend suggesting that those with unexpected abnormal results perceived 
them to be less accurate than those with expected negative results. Nevertheless, those receiving 
unexpected negative results appeared to perceive the results to be least accurate. Individuals 
requiring follow-up (whether or not expected) reported higher levels of concern about the scan result 
than those receiving negative results. While greater concern about the test result was found for 
those in most deprived areas, those with experience of lung cancer and younger people, these 
associations did not account for the relationship between expectation-result congruence and 
concern.   
 
Renner [19] suggests that health-related feedback may elicit different levels of processing 
depending on feedback expectation, with the CARA model hypothesising that unexpected and 
abnormal information is more elaborately processed, thus perceived as more concerning and less 
accurate. [25] Furthermore, the CARA model suggests that the consistency of information received 
at different time points also affects perceptions of threat and accuracy [19]. The present study 
findings in the main support the CARA model as both expectations and actual test result were 
important for the response to the result, with expected negative results requiring less processing 
than other results. With regards to perceived accuracy, there was only a trend to support a 
combined effect of unexpected and adverse results. This combined effect has been shown by 
Shepperd and colleagues [26] who found that smokers given a hypothetical genetic lung cancer 
risk-screening test were least willing to accept genetic risk feedback when they received 
unexpected unfavourable results as they had higher desire for a retest. In contrast, unexpected 
negative results were perceived to be least accurate in the present study. This result is in contrast to 
Renner’s [19] own findings that unexpected abnormal results were perceived to be least accurate. 
Renner [19] suggests that unexpected negative results may potentially be false-negative results 
within a health setting, hence important for a person to consider and examine carefully for their 
accuracy.  
 
The present study showed that an unfavourable test result had an influence on concern about the 
result irrespective of expectation, suggesting that the need for follow-up is responsible for greater 
concern, rather than the congruence with existing beliefs. These findings contradict the notion that 
the combination of unexpected and adverse results creates more concern than adverse results 
alone. Shepperd and colleagues also found that unfavourable results were more relevant and 
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resulted in more negative affect regardless of expectation. The CARA model has also been 
examined by Bennett et al. [27], whose results did not support the model as levels of intrusive 
cancer-related thoughts decreased among women after receiving their genetic risk assessment 
result, regardless of the risk assigned and of level of surprise (indexing expectation).  
 
Understanding how individuals react to health-risk information is gaining importance as health 
assessments where results are not immediate, such as cancer screening, are becoming 
increasingly common. It is well documented that abnormal cancer screening results can cause 
significant short-term distress, reducing individuals’ quality of life [28]. For instance, Watson et al. 
[15] found the negative psychological impact of a marginally abnormal mammogram, requiring 
further testing, was significantly higher than for a normal mammogram. Furthermore, this occurred 
even if the second test was normal [15]. Within the present study many individuals (52.4%) required 
follow-up before receiving their final screening outcome. However, it should be highlighted that 
requiring follow-up did not necessarily mean there was a suspicion of lung cancer and it is likely the 
number requiring follow-up would be lower should a national screening lung cancer programme be 
introduced [11]. Within the trial, those with category two nodules (defined as small and probably 
benign) required a follow-up scan at 12 months as part of the trial protocol. However, as part of a 
national programme these would not require follow-up and a programme would likely involve annual 
or biennial scans [11]. The implications of these results for future screening should therefore be 
considered with this in mind.  
 
The results of the present study should also be viewed in light of the previous studies examining the 
psychological impact of lung screening, many of which have shown no evidence of long-term 
negative psychological outcomes. Previously reported analyses of the UKLS study have shown 
increases in lung cancer distress and anxiety after receiving an MDT referral in the short-term, but 
no evidence of a long-term impact [17]. The NELSON trial reported lower quality of life and 
increased anxiety and cancer distress at two months follow-up after an indeterminate scan result, 
but these effects had resolved by two years [29]. The NLST reported no significant differences 
between those receiving an abnormal versus normal lung screening result in anxiety and health-
related quality of life at one and six months follow-up [30]. Thus while potential short-term negative 
impacts may be beneficial to address, it is encouraging that longer-term negative psychological 
outcomes from lung screening appear to be limited. Indeed, further exploration of whether concern 
about CT result and perceived accuracy of the result are associated with other long-term 
psychological outcomes such as cancer distress would be interesting. 
 
It is noteworthy that no association was found between smoking status and concern about the CT 
result. This is in contrast to previous analyses of the UKLS pilot trial where smokers were more 
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distressed about lung cancer than non-smokers were [17]. This may highlight the differences 
between examining concern about the CT result and a broader measure of distress about lung 
cancer.   
 
Some limitations to the present study are acknowledged. There may be selection bias as an 
individual’s decision to participate in a trial is different to deciding to participate in a national 
screening programme. Although randomised controlled trials are the gold standard for evidence-
based decision-making their results may be limited when generalising to a national programme [31]. 
Furthermore, sample selection bias may limit external validity, as high-risk individuals who were 
older, female, smokers, from a lower socioeconomic group or more concerned about lung cancer 
were less likely to participate [32]. Smokers may have been further under-represented because 
smoking status was computed from self-reported information and there is a risk of social-desirability 
bias. However, previous studies have shown the validity of self-reported smoking status to be high 
[33], including in the NELSON lung cancer screening trial [34]. Once taking part in the UKLS pilot 
trial, those included in the present sample were similar to those who did not complete the follow up-
questionnaire except more were married/cohabiting and they were better educated. These 
differences in characteristics further limit the generalisability of the findings. The measures of 
concern (indexing perceived threat from the CARA model) and perceived accuracy were both 
assessed using single items which resulted in limited variability of these measures. Single item 
measures were used to minimize participant burden as they were within longer questionnaires [22]. 
Finally, the element of consistency of feedback over multiple time points, posited by the CARA 
model to influence the response to results, was not examined within this study.  
 
4.2. Conclusion   
The findings support the CARA model as those receiving expected negative results view them as 
less concerning and more accurate than those receiving other results. Individuals requiring follow-
up after their initial LCDT scan have greater concern about the result than those receiving negative 
results.  While concern was associated with some sociodemographic variables, they did not account 
for the association between expectation-result congruence and concern about the test result. Those 
receiving unexpected negative results appear to perceive the test to be less accurate. Groups who 
may benefit from additional support during the screening process can therefore be identified. 
 
4.3. Practical Implications  
Identifying those at higher risk of perceiving the CT test results to be more concerning and less 
accurate is possible. This is important for future lung cancer screening programmes, which are likely 
to be annual or biennial [11], because evidence suggests that increased concern and decreased 
perceived accuracy can result in patients avoiding future surveillance [35-37]. Individuals with 
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unfavourable screening results and those with unexpected results may benefit from additional 
support during the screening process. For those receiving unexpected negative results, help in 
appreciating the accuracy of the test results may be valuable. This may be particularly important for 
a group already defined as “high-risk”, as a false-positive for this group may be particularly 
concerning. However, only a small proportion (<20%) of participants expected an unclear or 
abnormal scan result despite being in a high-risk group. For those requiring follow-up, additional 
support to cope with their result and understand the likelihood (or in reality more the unlikelihood) of 
a cancer actually being detected may be important. If lung cancer screening is routinely 
implemented, interventions for specific expectation-result groups may be developed for use within 
the screening programme to minimise any adverse psychological impact of the screening process. 
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Table 1. Baseline sample characteristics  
 
 
Final sample 
(n = 1589) ‡ 
n (%) 
Age  
≤65 478 (30.1) 
66 to 70 698 (43.9) 
≥71 413 (26.0) 
Gender 
Male  1203 (75.7) 
Female 386 (24.3) 
Education^  
Up to GCSE/O level or equivalent  491 (43.6) 
Beyond GCSE/O level or equivalent 636 (56.4) 
Ethnicity  
White  1570 (99.2) 
Non-white 12 (0.8) 
Marital group  
Married /cohabiting  1199 (75.7) 
Not married/cohabiting*  385 (24.3) 
IMD 
Quintile 1 428 (26.9) 
Quintile 2 186 (11.7) 
Quintile 3 281 (17.7) 
Quintile 4  270 (17.0) 
Quintile 5 424 (26.7) 
Smoking status 
Current smoker 589 (37.6) 
Ex-smoker 990 (62.3) 
Never smoker 1 (0.1) 
Experience of 
lung cancer 
No 1098 (58.2) 
Yes 789 (41.8) 
‡Ns vary within each cell due to missing data. Percentages are calculated based on available data. 
^a substantial amount of data were missing or uninformative for education. 
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Table 2. Expected and actual LDCT scan results 
  LDCT Scan Result, n (%) 
  Negative Follow-up 
Screening 
expectation, 
n (%) 
Negative 634 (39.9) 675 (42.5) 
Unclear/Abnormal 123 (7.7) 157 (9.9) 
 
 
 
Table 3. Expectation-result congruence and concern about the LDCT scan result  
 
Not at all 
concerned 
n (%) 
Not very 
concerned 
n (%) 
Fairly 
concerned 
n (%) 
Very 
concerned 
n (%) 
 
Expected negativea 332 (56.8) 123 (21.1) 107 (18.3) 22 (3.8) 
 
Other expectation-
result groups (break 
down below) 
146 (17.0) 250 (29.2) 345 (40.3) 116 (13.5) 
χ²(3)=262.7 
p<0.001† 
 
Unexpected 
follow-up 
85 (14.2) 189 (31.5) 249 (41.5) 77 (12.8) 
 
 
Unexpected 
negativeb 
48 (42.5) 24 (21.2) 26 (23.0) 15 (13.3) 
 
 
Expected 
follow-upc 
13 (9.0) 37 (34.7) 70 (48.6) 24 (16.7) 
χ²(9)=309.7 
p<0.001∆ 
∆ overall chi-square test including the four expectation-result congruence groups. 
† expected negative and other expectation results group (combined). 
a unexpected follow-up and expected negative groups only: χ²(3)=247.3, p<0.001. 
b unexpected follow-up and unexpected negative groups only: χ²(3)=52.7, p<0.001. 
c unexpected follow-up and expected follow-up groups only: χ²(3)=6.2, p=0.1. 
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Table 4. Expectation-result congruence and perceived accuracy about the LDCT scan result  
 Likely that LDCT scan 
result was accurate 
n (%) 
Unlikely that LDCT scan 
result was accurate 
n (%) 
 
Expected negativea 553 (94.7) 31 (5.3)  
Other expectation-
result groups (break 
down below) 
773 (90.5) 81 (9.5) 
χ²(1)=7.9 
p=0.005† 
 
Unexpected 
follow-up 
545 (91.1) 53 (8.9)  
 
Unexpected 
negativeb 
96 (85.7) 16 (14.3)  
 
Expected 
follow-upc 
132 (91.7) 12 (8.3) 
χ²(3)=12.6 
p=0.006∆ 
∆ overall chi-square test including the four expectation-result congruence groups. 
† expected negative and other expectation results group (combined). 
a unexpected follow-up and expected negative groups only: χ²(1)=5.1, p=0.02. 
b unexpected follow-up and unexpected negative groups only: χ²(1)=2.6, p=0.11. 
c unexpected follow-up and expected follow up groups only: χ²(1)=0.001, p=0.97. 
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Table 5. Sociodemographics and concern about the LDCT scan result  
◊ Ns vary within each cell due to missing data. Percentages are calculated based on available data  
* Data excluded from analysis due to small cell size 
** The post-hoc test shows this group is significantly younger than those who were not at all concerned  
 
 
 
 
 
Not at all 
concerned 
(n=478) 
n (%) or mean 
(SD) 
Not very 
concerned 
(n=373) 
n (%) or mean 
(SD) 
Fairly concerned 
(n=452) 
n (%) or mean 
(SD) 
Very concerned 
(n=138) 
n (%) or mean 
(SD) 
Test statistic 
(p-value) 
Age 67.96 (4.01) 67.68 (3.99) 67.45 (3.75) 66.79 (4.10)** 
F(3,1437) = 3.6 
(0.01) 
Gender 
Male 386 (81) 280 (75) 335 (74) 99 (72) 
χ² (3) = 8.3 (0.04) 
Female 92 (19) 93 (25) 117 (26) 39 (28) 
IMD 
Quintile 1 116 (24) 86 (23) 124 (27) 55 (40) 
χ² (12) = 25.1 
(0.01) 
Quintile 2 61 (13) 43 (12) 46 (10) 13 (9) 
Quintile 3 89 (19) 65 (17) 81 (18) 23 (17) 
Quintile 4 73 (15) 66 (18) 86 (19) 25 (18) 
Quintile 5 139 (29) 113 (30) 115 (25) 22 (16) 
Marital group  
Married/cohabiting  354 (74) 296 (79) 342 (76) 101 (74) 
χ² (3) = 3.4 (0.34) 
Not married/cohabiting 122 (26) 77 (21) 108 (24) 36 (26) 
Experience of 
lung cancer  
No 292 (61) 
232 (62) 
 
253 (56) 66 (48) 
χ² (3) = 11.5 (0.01) 
Yes 184 (39) 140 (38) 199 (44) 72 (52) 
Smoking status 
Current smoker 158 (33) 140 (38) 181 (40) 55 (40) 
χ² (3) = 5.5 (0.14) 
Ex-smoker 320 (67) 232 (62) 271 (60) 83 (60) 
Never smoker* 0 (0) 1 (<1) 0 (0) 0 (0) n/a 
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Table 6. Sociodemographics and perceived accuracy of the LDCT scan result  
 Likely CT scan was 
accurate (n=1326) 
n (%) or mean (SD) 
Unlikely CT scan was 
accurate (n=112) 
n (%) or mean (SD) 
Test statistic 
(p-value) 
Age 67.63 (3.95) 67.42 (3.99) t (1436) = 0.5 (0.59) 
Gender 
Male 1019 (77) 79 (71) 
χ² (1) = 1.9 (0.16) 
Female 307 (23) 33 (30) 
IMD 
Quintile 1 348 (26) 34 (30) 
χ² (4) = 1.7 (0.80) 
Quintile 2 151 (11) 10 (9) 
Quintile 3 236 (18) 21 (19) 
Quintile 4 230 (17) 20 (18) 
Quintile 5 361 (27) 27 (24) 
Marital group  
Married/cohabiting 1008 (76) 82 (73) 
χ² (1) = 0.4 (0.54) 
Not married/cohabiting 313 (24) 30 (27) 
Experience of 
lung cancer  
No 772 (58) 68 (61) 
χ² (1) = 0.2 (0.70) 
Yes 551 (42) 44 (39) 
Smoking status  
Current smoker 497 (38) 37 (33) 
χ² (1) = 0.7 (0.40) 
Ex-smoker 828 (63) 75 (67) 
Never smoker* 1 (<1) 0 (0) n/a 
◊ Ns vary within each cell due to missing data. Percentages are calculated based on available data  
* Data excluded from analysis due to small cell size 
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Figure captions 
Figure 1. Study participation  
  
 
Randomised trial participants 4055 
T0 completed 2018 (99.5%) 
T0 no data 10 
 (Total 2028) 
T1 completers included in analysis 1589 (84.1%) 
T1 not completed 301 
(Total 1890) 
 
T1 completed 1653 (84.1%) 
T1 not completed 312 
(Total 1965) 
Excluded: control group 2027 
Excluded: protocol deviation 63 (no T0 data 
10, T1 not sent 34, protocol deviation T1 19) 
CT scan group 2028 
Excluded: scan result had discrepancies 
13, negative with incidental finding 51, 
participant did not indicate a scan result 
expectation 11 
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Highlights 
 Requiring follow-up is associated with higher concern about results.  
 An unexpected negative LDCT scan result is perceived as less accurate. 
 Extra support may be beneficial for some during the screening process.  
 
